Everest Medicines Limited (HKG:1952)
Hong Kong
· Delayed Price · Currency is HKD 57.20
+0.95 (1.69%)
Jun 27, 2025, 4:08 PM HKT
Everest Medicines Market Cap
Everest Medicines has a market cap or net worth of 16.63 billion as of June 27, 2025. Its market cap has increased by 125.17% in one year.
Market Cap
16.63B
Enterprise Value
15.53B
Revenue
752.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
57.20
Market Cap Chart
Since October 9, 2020, Everest Medicines's market cap has decreased from 20.64B to 16.63B, a decrease of -19.44%. That is a compound annual growth rate of -4.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 16.63B | 6.64% |
| Dec 31, 2024 | 15.59B | 132.87% |
| Dec 29, 2023 | 6.70B | 24.60% |
| Dec 30, 2022 | 5.37B | -47.96% |
| Dec 31, 2021 | 10.33B | -47.98% |
| Dec 31, 2020 | 19.85B | -3.81% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 248.50B |
| Hansoh Pharmaceutical Group Company | 174.21B |
| Innovent Biologics | 136.09B |
| JD Health International | 131.84B |
| WuXi Biologics | 103.34B |
| Sino Biopharmaceutical | 93.72B |
| CSPC Pharmaceutical Group | 91.21B |
| Akeso | 88.01B |